Premium
O‐010: A phase 2 dose‐optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—analysis from the LOWR HDV‐2 study using the robogene ® real‐time qPCR HDV RNA assay
Publication year - 2018
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/jvh.08_12922
Subject(s) - hepatitis d , chronic hepatitis , ritonavir , citation , covid-19 , medicine , virology , library science , computer science , human immunodeficiency virus (hiv) , viral load , hepatitis b virus , antiretroviral therapy , virus , hbsag , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom